Logo of heartHeartVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
Heart. 2001 Dec; 86(6): 701–708.
PMCID: PMC1729995

Transforming growth factor-β1 expression in dilated cardiomyopathy

Full Text

The Full Text of this article is available as a PDF (247K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med. 2000 May 4;342(18):1350–1358. [PubMed]
  • Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, Hsueh WA. Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation. 2000 Mar 14;101(10):1130–1137. [PubMed]
  • Di Somma S, Marotta M, Salvatore G, Cudemo G, Cuda G, De Vivo F, Di Benedetto MP, Ciaramella F, Caputo G, de Divitiis O. Changes in myocardial cytoskeletal intermediate filaments and myocyte contractile dysfunction in dilated cardiomyopathy: an in vivo study in humans. Heart. 2000 Dec;84(6):659–667. [PMC free article] [PubMed]
  • Kühl U, Seeberg B, Schultheiss HP, Strauer BE. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. Eur Heart J. 1994 Aug;15 (Suppl 100):62–67. [PubMed]
  • Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, Kühl U, Schultheiss HP. Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation. 1999 Jun 1;99(21):2750–2756. [PubMed]
  • Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R, Jr, Ellis MC, Fullan A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet. 1996 Aug;13(4):399–408. [PubMed]
  • Whitfield JB, Cullen LM, Jazwinska EC, Powell LW, Heath AC, Zhu G, Duffy DL, Martin NG. Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet. 2000 Apr;66(4):1246–1258. [PMC free article] [PubMed]
  • Mahon NG, Coonar AS, Jeffery S, Coccolo F, Akiyu J, Zal B, Houlston R, Levin GE, Baboonian C, McKenna WJ. Haemochromatosis gene mutations in idiopathic dilated cardiomyopathy. Heart. 2000 Nov;84(5):541–547. [PMC free article] [PubMed]
  • Tesson F, Charron P, Peuchmaurd M, Nicaud V, Cambien F, Tiret L, Poirier O, Desnos M, Jullières Y, Amouyel P, et al. Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. CARDIGENE Group. J Mol Cell Cardiol. 1999 May;31(5):1025–1032. [PubMed]
  • Gras D, Mabo P, Tang T, Luttikuis O, Chatoor R, Pedersen AK, Tscheliessnigg HH, Deharo JC, Puglisi A, Silvestre J, et al. Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol. 1998 Nov;21(11 Pt 2):2249–2255. [PubMed]
  • de Groote P, Millaire A, Decoulx E, Nugue O, Guimier P, Ducloux Kinetics of oxygen consumption during and after exercise in patients with dilated cardiomyopathy. New markers of exercise intolerance with clinical implications. J Am Coll Cardiol. 1996 Jul;28(1):168–175. [PubMed]
  • Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, Nishibata K. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol. 1996 Nov 15;28(6):1567–1572. [PubMed]
  • Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, Coats AJ. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). Eur Heart J. 2000 Jan;21(2):154–161. [PubMed]
  • Mancini D, LeJemtel T, Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation. 2000 Mar 14;101(10):1080–1082. [PubMed]
  • Shibata M, Endo S, Inada K, Kuriki S, Harada M, Takino T, Sato N, Arakawa N, Suzuki T, Aoki H, et al. Elevated plasma levels of interleukin-1 receptor antagonist and interleukin-10 in patients with acute myocardial infarction. J Interferon Cytokine Res. 1997 Mar;17(3):145–150. [PubMed]
  • Yang Z, Zingarelli B, Szabó C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation. 2000 Mar 7;101(9):1019–1026. [PubMed]
  • Frangogiannis NG, Mendoza LH, Lindsey ML, Ballantyne CM, Michael LH, Smith CW, Entman ML. IL-10 is induced in the reperfused myocardium and may modulate the reaction to injury. J Immunol. 2000 Sep 1;165(5):2798–2808. [PubMed]
  • Kanda T, Inoue M, Kotajima N, Fujimaki S, Hoshino Y, Kurabayashi M, Kobayashi I, Tamura J. Circulating interleukin-6 and interleukin-6 receptors in patients with acute and recent myocardial infarction. Cardiology. 2000;93(3):191–196. [PubMed]
  • Kaneko K, Kanda T, Yokoyama T, Nakazato Y, Iwasaki T, Kobayashi I, Nagai R. Expression of interleukin-6 in the ventricles and coronary arteries of patients with myocardial infarction. Res Commun Mol Pathol Pharmacol. 1997 Jul;97(1):3–12. [PubMed]
  • Cohen MC, Hartnell GG, Finn JP. Magnetic resonance angiography of congenital pulmonary vein anomalies. Am Heart J. 1994 Apr;127(4 Pt 1):954–955. [PubMed]
  • White CS, Baffa JM, Haney PJ, Campbell AB, NessAiver M. Anomalies of pulmonary veins: usefulness of spin-echo and gradient-echo MR images. AJR Am J Roentgenol. 1998 May;170(5):1365–1368. [PubMed]
  • Prince MR, Narasimham DL, Jacoby WT, Williams DM, Cho KJ, Marx MV, Deeb GM. Three-dimensional gadolinium-enhanced MR angiography of the thoracic aorta. AJR Am J Roentgenol. 1996 Jun;166(6):1387–1397. [PubMed]
  • Kivelitz DE, Scheer I, Taupitz M. Scimitar syndrome: diagnosis with MR angiography. AJR Am J Roentgenol. 1999 Jun;172(6):1700–1700. [PubMed]
  • Baxter R, McFadden PM, Gradman M, Wright A. Scimitar syndrome: cine magnetic resonance imaging demonstration of anomalous pulmonary venous drainage. Ann Thorac Surg. 1990 Jul;50(1):121–123. [PubMed]
  • Bonhoeffer P, Boudjemline Y, Saliba Z, Hausse AO, Aggoun Y, Bonnet D, Sidi D, Kachaner J. Transcatheter implantation of a bovine valve in pulmonary position: a lamb study. Circulation. 2000 Aug 15;102(7):813–816. [PubMed]
  • Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, Acar P, Le Bidois J, Sidi D, Kachaner J. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet. 2000 Oct 21;356(9239):1403–1405. [PubMed]
  • Anderson TJ. Assessment and treatment of endothelial dysfunction in humans. J Am Coll Cardiol. 1999 Sep;34(3):631–638. [PubMed]
  • Paris D, Town T, Humphrey J, Yokota K, Mullan M. Cholesterol modulates vascular reactivity to endothelin-1 by stimulating a pro-inflammatory pathway. Biochem Biophys Res Commun. 2000 Aug 2;274(2):553–558. [PubMed]
  • Verma S, Lovren F, Dumont AS, Mather KJ, Maitland A, Kieser TM, Triggle CR, Anderson TJ. Tetrahydrobiopterin improves endothelial function in human saphenous veins. J Thorac Cardiovasc Surg. 2000 Oct;120(4):668–671. [PubMed]
  • Galle J, Lehmann-Bodem C, Hübner U, Heinloth A, Wanner C. CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation. Nephrol Dial Transplant. 2000 Mar;15(3):339–346. [PubMed]
  • Mangiafico RA, Malatino LS, Santonocito M, Spada RS, Polizzi G, Tamburino G. Raised plasma endothelin-1 concentrations in patients with primary hypercholesterolemia without evidence of atherosclerosis. Int Angiol. 1996 Sep;15(3):240–244. [PubMed]
  • Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart. 2001 Oct;86(4):381–386. [PMC free article] [PubMed]
  • Eykyn SJ. Endocarditis: basics. Heart. 2001 Oct;86(4):476–480. [PMC free article] [PubMed]
  • Ho SY, Cabrera JA, Tran VH, Farré J, Anderson RH, Sánchez-Quintana D. Architecture of the pulmonary veins: relevance to radiofrequency ablation. Heart. 2001 Sep;86(3):265–270. [PMC free article] [PubMed]
  • Berkin KE, Ball SG. Essential hypertension: the heart and hypertension. Heart. 2001 Oct;86(4):467–475. [PMC free article] [PubMed]
  • Chambers J, Das P. Treadmill exercise in apparently asymptomatic aortic stenosis. Heart. 2001 Oct;86(4):361–362. [PMC free article] [PubMed]
  • Jardine AG, McLaughlin K. Cardiovascular complications of renal disease. Heart. 2001 Oct;86(4):459–466. [PMC free article] [PubMed]
  • Hancock EW. Differential diagnosis of restrictive cardiomyopathy and constrictive pericarditis. Heart. 2001 Sep;86(3):343–349. [PMC free article] [PubMed]
  • Möller J, Ahlbom A, Hulting J, Diderichsen F, de Faire U, Reuterwall C, Hallqvist J. Sexual activity as a trigger of myocardial infarction. A case-crossover analysis in the Stockholm Heart Epidemiology Programme (SHEEP). Heart. 2001 Oct;86(4):387–390. [PMC free article] [PubMed]
  • Rakhit RD, Marber MS. Nitric oxide: an emerging role in cardioprotection? Heart. 2001 Oct;86(4):368–372. [PMC free article] [PubMed]

Figures and Tables

Figure 1
Scattergram showing individual values for serum TGF-β1 concentrations (upper) and macrophage mRNA concentrations (lower). DCM, idiopathic dilated cardiomyopathy.

Articles from Heart are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Compound
    PubChem Compound links
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...